Lonza Invests CHF 20 million to Expand API Development and Manufacturing Facility in Nansha, China
New investments will include three 1,000L GMP trains with an overall 12m3 of reactor volume
01-Jul-2021 -
Lonza today announced new investments in GMP laboratories and mid-scale manufacturing assets at its API manufacturing center in Nansha, China. The investments, totaling over CHF 20 million, will allow Lonza to provide a smoother transition from small-scale to large-scale manufacturing for ...
API development
investments
laboratories
+1